Advanced search
Publication Cover
Vascular Health and Risk Management Volume 12, 2016 - Issue
Submit an article Journal homepage
55
Views
5
CrossRef citations to date
0
Altmetric
Short Report

Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

James E Foley1 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USACorrespondence[email protected]
,
Vaishali Bhosekar2 Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
&
Ryuzo Kawamori3 Sportology Center, Juntendo University Graduate School of Medicine, Juntendo University, Tokyo, Japan
Pages 9-12 | Published online: 21 Jan 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.